E. Scheibel

发表

A multicenter study of recombinant factor VIII (recombinate): safety, efficacy, and inhibitor risk in previously untreated patients with hemophilia A. The Recombinate Study Group.

E. Gordon, E. Gomperts, A. Shapiro, 1994, Blood.

Incidence of childhood cancer in Denmark 1943-1984.

J. Olsen, P. de Nully Brown, E. Scheibel, 1989, International journal of epidemiology.

Autologous antibody response against the principal neutralizing domain of human immunodeficiency virus type 1 isolated from infected humans

T. Bugge, E. Scheibel, P. Kusk, 1993, Journal of virology.

VASOACTIVE INTESTINAL POLYPEPTIDE (VIP) IN CHILDREN WITH NEURAL CREST TUMOURS

J. Fahrenkrug, E. Scheibel, C. Rechnitzer, 1982, Acta paediatrica Scandinavica.

Limited protective effect of the CCR5Delta32/CCR5Delta32 genotype on human immunodeficiency virus infection incidence in a cohort of patients with hemophilia and selection for genotypic X4 virus.

Samuel M. Schulman, L. Fugger, A. Iversen, 2003, The Journal of infectious diseases.

Major surgery in haemophilic patients with inhibitors using recombinant factor VIIa.

E. Scheibel, D. Gastineau, H. Johnsson, 1996, Haemostasis.

Port‐A‐Cath usage in children with haemophilia: experience of 53 cases

R. Ljung, P. Petrini, L. Tengborn, 1998, Acta paediatrica.

Immunetolerance as treatment of alloantibodies to factor VIII in hemophilia. The International Registry of Immunetolerance Protocols.

G. Mariani, N. Ewing, C. Kasper, 1994, Seminars in hematology.

Can long‐term prophylaxis for severe haemophilia be stopped in adulthood? Results from Denmark and the Netherlands

K. Fischer, J. Bom, J. Ingerslev, 2005, British journal of haematology.

Treatment of children with haemophilia in Europe: a survey of 20 centres in 16 countries

M. Siimes, R. Ljung, H. Chambost, 2000, Haemophilia : the official journal of the World Federation of Hemophilia.

Approaches towards successful home treatment in patients with inhibitors

E. Scheibel, J. Ingerslev, H. Thykjær, 1998, European journal of haematology. Supplementum.

Long-term high dose factor VIII treatment of 3 haemophiliacs with factor VIII inhibitor.

E. Scheibel, H. Hertz, C. Feddersen, 2009, Scandinavian journal of haematology.

Factor VIII gene inversions in severe hemophilia A: results of an international consortium study.

F E Preston, P G Mori, S S Sommer, 1995, Blood.

Orthopaedics and Haemophilia

M. Blombäck, G. Lüchters, F. Mandelli, 1981 .

HIV infection in haemophilia--a European cohort.

E. MAUSER‐BUNSCHOTEN, E. Scheibel, F. Hill, 1993, Archives of disease in childhood.

Continuous High-Dose Factor VIII for the Induction of Immune Tolerance in Haemophilia A Patients with High Responder State: A Description of Eleven Patients Treated

J. Knudsen, J. Ingerslev, E. Scheibel, 1987, Thrombosis and Haemostasis.

Detection of Ten New Mutations by Screening the Gene Encoding Factor IX of Danish Hemophilia B Patients

M. Schwartz, J. Ingerslev, E. Scheibel, 1995, Thrombosis and Haemostasis.

Prenatal exclusion of haemophilia a and carrier testing by direct detection of a disease lesion

D. Cooper, V. Kakkar, M. Schwartz, 1992, Prenatal diagnosis.

Clinical use of DNA markers (RFLP) in genetic counselling and prenatal diagnosis of haemophilia A and B

M. Schwartz, E. Scheibel, Nanni Din, 1986 .

Alterations in T-lymphocyte subsets among Danish haemophiliacs: relation to source of factor VIII preparations and high dose factor VIII treatment.

E. Scheibel, J. Gerstoft, J. Gormsen, 2009, Scandinavian journal of haematology.

Absence of Correlation between X Chromosome Inactivation Pattern and Plasma Concentration of Factor VIII and Factor IX in Carriers of Haemophilia A and B

M. Schwartz, J. Ingerslev, E. Scheibel, 2000, Thrombosis and Haemostasis.

Correlation between hairy leukoplakia and immunologic status in HIV-infected Danish hemophiliacs.

E. Scheibel, M. Schiodt, J. Pindborg, 1987, AIDS.

Clinical course of primary HIV infection: consequences for subsequent course of infection.

E. Scheibel, C. Pedersen, B. L. Jensen, 1989, BMJ.

Type IIB von Willebrand's disease: gene mutations and clinical presentation in nine families from Denmark, Germany and Sweden

H. Lenk, E. Scheibel, I. Nilsson, 1992, British journal of haematology.

Two new candidate mutations in type IIA von Willebrand's disease (ARG834→GLY, GLY846→ARG) and one polymorphism (TYR821→CYS) in the A2 region of the von Willebrand factor

B. Dahlbäck, E. Berntorp, E. Scheibel, 1993, European journal of haematology.

Antibodies against HTLV-III in Danish haemophiliacs: relation to source of factor VIII used in treatment and immunological parameters.

E. Scheibel, J. Gerstoft, E. Dickmeiss, 2009, Scandinavian journal of haematology.

Pattern of Immunoglobulin Classes and IgG Subclasses of Platelet‐Associated Immunoglobulin in HIV‐Seropositive Haemophiliacs

E. Scheibel, J. Ingerslev, B. Laursen, 1988, Vox sanguinis.

Thrombocytopenia in HIV Seropositive Haemophiliacs: A Study of Platelet Associated Immunoglobulins

E. Scheibel, J. Ingerslev, E. Taaning, 1988 .

Neutralizing antibodies against two HIV-1 strains in consecutively collected serum samples: cross neutralization and association to HIV-1 related disease.

J. Hansen, J. Nielsen, M. Arendrup, 1992, Scandinavian journal of infectious diseases.

Serological markers of primary HIV infection.

E. Scheibel, C. Pedersen, B. Lindhardt, 1989, Scandinavian journal of infectious diseases.

Oral hairy leukoplakia in three hemophiliacs with human immunodeficiency virus infection.

E. Scheibel, M. Schiodt, J. Pindborg, 1987, Oral surgery, oral medicine, and oral pathology.

Passively Transmitted Antibodies to Human Immunodeficiency Virus in Haemophiliacs

E. Scheibel, J. Rosenkvist, J. Ingerslev, 1988, Vox sanguinis.

IIB von W illebr and' s disease : mutations and clinical presentation in nine families Denmark, Germany and Sweden

B. Dahlbäck, H. Lenk, E. Scheibel, 1992 .

Prognostic factors for relapse-free survival in childhood acute lymphoblastic leukaemia.

E. Scheibel, J. Nyboe, N. Clausen, 2009, Scandinavian journal of haematology.

Prenatal exclusion of severe factor VII deficiency by DNA sequencing

D. Cooper, V. Kakkar, M. Schwartz, 1992, The Lancet.